Gupta R S, Chenchaiah P C, Gupta R
Department of Biochemistry, McMaster University, Hamilton, Ontario, Canada.
Anticancer Drug Des. 1987 Aug;2(1):1-12.
We have synthesized acetal and ketal derivatives of 4'-demethylepipodophyllotoxin-beta-D-glucoside (DMEPG) and epipodophyllotoxin-beta-D-glucoside (EPG) with a number of different aldehydes (viz. acetaldehyde, propionaldehyde, 2-thiophenecarboxaldehyde, 3-thiophenecarboxaldehyde, 2-furancarboxaldehyde, benzaldehyde, phenylacetaldehyde, hydrocinnamaldehyde) and acetone. The cross resistance of these compounds towards a set of Chinese hamster ovary cell mutants resistant to either podophyllotoxin (PodR mutants) or VM26 (VpmR mutants) which exhibit mutually exclusive cross-resistance patterns toward compounds that show either podophyllotoxin- or VM26-like activities have been examined. Results of our studies show that, with the exception of 2-furan derivatives, all the remaining acetals and ketals of DMEPG and EPG showed similar cross-resistance patterns towards the VpmR and the PodR mutants, as seen with VM26 and VP16-213. These results provide strong suggestive evidence that all of these derivatives (except 2-furan) possess biological activities similar to VM26 and VP16-213, and that their cellular toxicities were due to this type of activity. The VM26-like behavior of different EPG derivatives, which lack the free 4'-OH group, provide evidence that a free 4'-OH group is not essential for VM26-like activity. However, in comparison to the EPG derivatives, the corresponding DMEPG compounds showed 10- to 30-fold higher activities, indicating an enhancing effect of the free 4'-OH group on this kind of activity. Some of the newly synthesized DMEPG and EPG derivatives show higher activity in comparison to VM26 and VP16-213, and structure-activity relationship among this group of compounds is discussed.
我们用多种不同的醛(即乙醛、丙醛、2-噻吩甲醛、3-噻吩甲醛、2-呋喃甲醛、苯甲醛、苯乙醛、氢化肉桂醛)和丙酮合成了4'-去甲基表鬼臼毒素-β-D-葡萄糖苷(DMEPG)和表鬼臼毒素-β-D-葡萄糖苷(EPG)的缩醛和缩酮衍生物。已检测了这些化合物对一组对鬼臼毒素(PodR突变体)或VM26(VpmR突变体)耐药的中国仓鼠卵巢细胞突变体的交叉耐药性,这些突变体对显示鬼臼毒素样或VM26样活性的化合物表现出相互排斥的交叉耐药模式。我们的研究结果表明,除2-呋喃衍生物外,DMEPG和EPG的所有其余缩醛和缩酮对VpmR和PodR突变体显示出与VM26和VP16-213相似的交叉耐药模式。这些结果提供了有力的暗示性证据,表明所有这些衍生物(2-呋喃除外)具有与VM26和VP16-213相似的生物活性,且它们的细胞毒性归因于这种活性。缺乏游离4'-OH基团的不同EPG衍生物的VM26样行为证明,游离4'-OH基团对于VM26样活性并非必不可少。然而,与EPG衍生物相比,相应的DMEPG化合物活性高10至30倍,表明游离4'-OH基团对这种活性有增强作用。一些新合成的DMEPG和EPG衍生物与VM26和VP16-213相比显示出更高的活性,并讨论了这组化合物之间的构效关系。